Published in Infect Immun on February 05, 2007
Pathogenesis of chagas' disease: parasite persistence and autoimmunity. Clin Microbiol Rev (2011) 1.38
Current understanding of immunity to Trypanosoma cruzi infection and pathogenesis of Chagas disease. Semin Immunopathol (2012) 1.26
Current concepts in immunoregulation and pathology of human Chagas disease. Curr Opin Infect Dis (2008) 1.17
Cellular and genetic mechanisms involved in the generation of protective and pathogenic immune responses in human Chagas disease. Mem Inst Oswaldo Cruz (2009) 1.11
Regulatory T cells phenotype in different clinical forms of Chagas' disease. PLoS Negl Trop Dis (2011) 1.10
Pharmacological inhibition of transforming growth factor beta signaling decreases infection and prevents heart damage in acute Chagas' disease. Antimicrob Agents Chemother (2009) 1.02
Inhibitory receptors are expressed by Trypanosoma cruzi-specific effector T cells and in hearts of subjects with chronic Chagas disease. PLoS One (2012) 0.95
TcVac3 induced control of Trypanosoma cruzi infection and chronic myocarditis in mice. PLoS One (2013) 0.95
Acute chagas disease: new global challenges for an old neglected disease. PLoS Negl Trop Dis (2014) 0.93
Trypanosoma cruzi-induced activation of functionally distinct αβ and γδ CD4- CD8- T cells in individuals with polar forms of Chagas' disease. Infect Immun (2010) 0.92
Regulation of Trypanosoma cruzi-induced myocarditis by programmed death cell receptor 1. Infect Immun (2011) 0.92
Matrix metalloproteinases 2 and 9 are differentially expressed in patients with indeterminate and cardiac clinical forms of Chagas disease. Infect Immun (2013) 0.90
Plasma cytokine expression is associated with cardiac morbidity in chagas disease. PLoS One (2014) 0.89
Trypanosoma cruzi induces regulatory dendritic cells in vitro. Infect Immun (2008) 0.88
Delivery of antigenic candidates by a DNA/MVA heterologous approach elicits effector CD8(+)T cell mediated immunity against Trypanosoma cruzi. Vaccine (2012) 0.84
Parasitic infections: a role for C-type lectins receptors. Biomed Res Int (2013) 0.83
Vesicles from different Trypanosoma cruzi strains trigger differential innate and chronic immune responses. J Extracell Vesicles (2015) 0.82
Protective human leucocyte antigen haplotype, HLA-DRB1*01-B*14, against chronic Chagas disease in Bolivia. PLoS Negl Trop Dis (2012) 0.79
Polymorphic sites at the immunoregulatory CTLA-4 gene are associated with chronic chagas disease and its clinical manifestations. PLoS One (2013) 0.79
Differential Activation of Human Monocytes and Lymphocytes by Distinct Strains of Trypanosoma cruzi. PLoS Negl Trop Dis (2015) 0.77
Changes in Proteome Profile of Peripheral Blood Mononuclear Cells in Chronic Chagas Disease. PLoS Negl Trop Dis (2016) 0.76
Cynomolgus macaques naturally infected with Trypanosoma cruzi-I exhibit an overall mixed pro-inflammatory/modulated cytokine signature characteristic of human Chagas disease. PLoS Negl Trop Dis (2017) 0.75
Mammalian cellular culture models of Trypanosoma cruzi infection: a review of the published literature. Parasite (2014) 0.75
Human leucocyte antigen-G (HLA-G) and its murine functional homolog Qa2 in the Trypanosoma cruzi Infection. Mediators Inflamm (2015) 0.75
Specific activation of CD4-CD8- double negative T cells by T. cruzi-derived glycolipids induces a pro-inflammatory profile associated with cardiomyopathy in Chagas patients. Clin Exp Immunol (2017) 0.75
Ebi3 Prevents Trypanosoma cruzi-Induced Myocarditis by Dampening IFN-γ-Driven Inflammation. Front Immunol (2017) 0.75
CTLA-4 can function as a negative regulator of T cell activation. Immunity (1994) 9.80
The role of the CD28 receptor during T cell responses to antigen. Annu Rev Immunol (1993) 5.65
IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages. J Immunol (1992) 3.98
Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Immunity (1994) 3.73
Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function. J Exp Med (1994) 3.24
Intracellular trafficking of CTLA-4 and focal localization towards sites of TCR engagement. Immunity (1996) 2.74
Characterization of CTLA-4 structure and expression on human T cells. J Immunol (1993) 2.68
IL-10 is produced by subsets of human CD4+ T cell clones and peripheral blood T cells. J Immunol (1992) 2.67
Co-stimulation in T cell responses. Curr Opin Immunol (1997) 2.35
Modulation of TCR-induced transcriptional profiles by ligation of CD28, ICOS, and CTLA-4 receptors. Proc Natl Acad Sci U S A (2002) 2.32
Decreased in situ expression of interleukin-10 receptor is correlated with the exacerbated inflammatory and cytotoxic responses observed in mucosal leishmaniasis. Infect Immun (2005) 2.29
Activated inflammatory T cells correlate with lesion size in human cutaneous leishmaniasis. Immunol Lett (2005) 1.94
Flow cytometric determination of cellular sources and frequencies of key cytokine-producing lymphocytes directed against recombinant LACK and soluble Leishmania antigen in human cutaneous leishmaniasis. Infect Immun (2001) 1.90
Chemokines, inflammation and Trypanosoma cruzi infection. Trends Parasitol (2002) 1.88
Evidence that development of severe cardiomyopathy in human Chagas' disease is due to a Th1-specific immune response. Infect Immun (2003) 1.81
Characterization of inflammatory infiltrates in chronic chagasic myocardial lesions: presence of tumor necrosis factor-alpha+ cells and dominance of granzyme A+, CD8+ lymphocytes. Am J Trop Med Hyg (1993) 1.73
Differential up-regulation of the B7-1 and B7-2 costimulatory molecules after Ig receptor engagement by antigen. J Immunol (1994) 1.61
Genetic characterization of Trypanosoma cruzi directly from tissues of patients with chronic Chagas disease: differential distribution of genetic types into diverse organs. Am J Pathol (2000) 1.52
Regulation of cell surface expression of CTLA-4 by secretion of CTLA-4-containing lysosomes upon activation of CD4+ T cells. J Immunol (2000) 1.39
Clinical management of chronic Chagas cardiomyopathy. Front Biosci (2003) 1.34
Monocytes from patients with indeterminate and cardiac forms of Chagas' disease display distinct phenotypic and functional characteristics associated with morbidity. Infect Immun (2004) 1.33
Cardiac gene expression profiling provides evidence for cytokinopathy as a molecular mechanism in Chagas' disease cardiomyopathy. Am J Pathol (2005) 1.32
Immunopathology of Chagas disease. Mem Inst Oswaldo Cruz (1999) 1.31
Mucosal leishmaniasis patients display an activated inflammatory T-cell phenotype associated with a nonbalanced monocyte population. Scand J Immunol (2006) 1.24
The clinical immunology of human Chagas disease. Trends Parasitol (2005) 1.19
Functional characterization of human IL-10. Int Arch Allergy Immunol (1992) 1.19
Immunohistochemical characterization of infiltrating cells in human chronic chagasic myocarditis: comparison with myocardial rejection process. Virchows Arch A Pathol Anat Histopathol (1993) 1.17
Activated T and B lymphocytes in peripheral blood of patients with Chagas' disease. Int Immunol (1994) 1.16
T lymphocyte co-signaling pathways of the B7-CD28 family. Cell Mol Immunol (2004) 1.14
Chagasic patients lack CD28 expression on many of their circulating T lymphocytes. Scand J Immunol (1996) 1.14
Regulatory role of Toll-like receptor 2 during infection with Trypanosoma cruzi. J Endotoxin Res (2004) 1.11
Negative feedback of T cell activation through inhibitory adapters and costimulatory receptors. Immunol Rev (2003) 1.10
Expression of inducible nitric oxide synthase in skin lesions of patients with american cutaneous leishmaniasis. Infect Immun (2002) 1.08
Phenotypic and functional characteristics of CD28+ and CD28- cells from chagasic patients: distinct repertoire and cytokine expression. Clin Exp Immunol (2004) 1.04
Cytokine mRNA profile of peripheral blood mononuclear cells isolated from individuals with Trypanosoma cruzi chronic infection. Scand J Immunol (1997) 1.04
Defective CTLA-4 cycling pathway in Chediak-Higashi syndrome: a possible mechanism for deregulation of T lymphocyte activation. Proc Natl Acad Sci U S A (1999) 1.00
T-cell molecular mimicry in Chagas disease: identification and partial structural analysis of multiple cross-reactive epitopes between Trypanosoma cruzi B13 and cardiac myosin heavy chain. J Autoimmun (2005) 0.99
CTLA-4 blockage increases resistance to infection with the intracellular protozoan Trypanosoma cruzi. J Immunol (2004) 0.97
Self and nonself stimulatory molecules induce preferential expansion of CD5+ B cells or activated T cells of chagasic patients, respectively. Scand J Immunol (2000) 0.97
Immunity and immunosuppression in experimental visceral leishmaniasis. Braz J Med Biol Res (2004) 0.97
Cellular immune responses of chagasic patients to antigens derived from different Trypanosoma cruzi strains and clones. Am J Trop Med Hyg (1986) 0.93
Differential CD86 and CD40 co-stimulatory molecules and cytokine expression pattern induced by Trypanosoma cruzi in APCs from resistant or susceptible mice. Clin Exp Immunol (2003) 0.91
The role of IL-12 in experimental Trypanosoma cruzi infection. Braz J Med Biol Res (1998) 0.90
Human T-cell responses in Leishmania infections. Prog Clin Parasitol (1993) 0.90
Polarized Th2 like cells, in the absence of Th0 cells, are responsible for lymphocyte produced IL-4 in high IgE-producer schistosomiasis patients. BMC Immunol (2002) 0.88
CD28 is required for T cell activation and IFN-gamma production by CD4+ and CD8+ T cells in response to Trypanosoma cruzi infection. Microbes Infect (2004) 0.84
Systemic leukocyte activation in patients with central giant cell lesions. J Oral Pathol Med (2005) 0.81
Molecules that inhibit T-cell functions: cytochemical localization and shuttling. Eur J Histochem (2000) 0.77
Up-regulation of Th1-type responses in mucosal leishmaniasis patients. Infect Immun (2002) 2.90
Decreased in situ expression of interleukin-10 receptor is correlated with the exacerbated inflammatory and cytotoxic responses observed in mucosal leishmaniasis. Infect Immun (2005) 2.29
Risk estimation approach in Chagas disease is still needed. Int J Cardiol (2010) 1.98
Activated inflammatory T cells correlate with lesion size in human cutaneous leishmaniasis. Immunol Lett (2005) 1.94
Diagnosis and management of Chagas disease and cardiomyopathy. Nat Rev Cardiol (2012) 1.45
Exacerbated inflammatory cellular immune response characteristics of HAM/TSP is observed in a large proportion of HTLV-I asymptomatic carriers. BMC Infect Dis (2004) 1.39
Monocytes from patients with indeterminate and cardiac forms of Chagas' disease display distinct phenotypic and functional characteristics associated with morbidity. Infect Immun (2004) 1.33
Current understanding of immunity to Trypanosoma cruzi infection and pathogenesis of Chagas disease. Semin Immunopathol (2012) 1.26
Functional IL-10 gene polymorphism is associated with Chagas disease cardiomyopathy. J Infect Dis (2009) 1.26
Current concepts in immunoregulation and pathology of human Chagas disease. Curr Opin Infect Dis (2008) 1.17
Disparate immunoregulatory potentials for double-negative (CD4- CD8-) alpha beta and gamma delta T cells from human patients with cutaneous leishmaniasis. Infect Immun (2006) 1.15
Elevated concentrations of CCL2 and tumor necrosis factor-alpha in chagasic cardiomyopathy. Clin Infect Dis (2004) 1.14
Dysautonomia due to reduced cholinergic neurotransmission causes cardiac remodeling and heart failure. Mol Cell Biol (2010) 1.12
Interleukin 17 production among patients with American cutaneous leishmaniasis. J Infect Dis (2009) 1.12
Cellular and genetic mechanisms involved in the generation of protective and pathogenic immune responses in human Chagas disease. Mem Inst Oswaldo Cruz (2009) 1.11
A functional interleukin-1 beta gene polymorphism is associated with chronic periodontitis in a sample of Brazilian individuals. J Periodontal Res (2005) 1.02
Chemokine receptor expression on the surface of peripheral blood mononuclear cells in Chagas disease. J Infect Dis (2004) 0.96
High interleukin 17 expression is correlated with better cardiac function in human Chagas disease. J Infect Dis (2012) 0.95
Immunoregulatory mechanisms and CD4-CD8- (double negative) T cell subpopulations in human cutaneous leishmaniasis: a balancing act between protection and pathology. Int Immunopharmacol (2008) 0.95
Left atrial volume provides independent prognostic value in patients with Chagas cardiomyopathy. J Am Soc Echocardiogr (2009) 0.94
Levels of anti-M2 and anti-beta1 autoantibodies do not correlate with the degree of heart dysfunction in Chagas' heart disease. Microbes Infect (2006) 0.93
Cutaneous leishmaniasis during pregnancy: exuberant lesions and potential fetal complications. Clin Infect Dis (2007) 0.93
Trypanosoma cruzi-induced activation of functionally distinct αβ and γδ CD4- CD8- T cells in individuals with polar forms of Chagas' disease. Infect Immun (2010) 0.92
IgG isotype profile is correlated with cardiomegaly in Beagle dogs infected with distinct Trypanosoma cruzi strains. Vet Immunol Immunopathol (2008) 0.92
Histopathological outcome of Leishmania major-infected BALB/c mice is improved by oral treatment with N-acetyl-l-cysteine. Immunology (2003) 0.91
Oxidant generation by single infected monocytes after short-term fluorescence labeling of a protozoan parasite. Infect Immun (2006) 0.91
Type I IFNs stimulate nitric oxide production and resistance to Trypanosoma cruzi infection. J Immunol (2006) 0.91
Norepinephrine, dopamine and dexamethasone modulate discrete leukocyte subpopulations and cytokine profiles from human PBMC. J Neuroimmunol (2005) 0.90
Interleukin-1 gene polymorphisms and toxoplasmic retinochoroiditis. Mol Vis (2008) 0.89
Polarized Th2 like cells, in the absence of Th0 cells, are responsible for lymphocyte produced IL-4 in high IgE-producer schistosomiasis patients. BMC Immunol (2002) 0.88
Insights into CD4+ memory T cells following Leishmania infection. Trends Parasitol (2005) 0.88
Predictors of mortality in patients with dilated cardiomyopathy: relevance of chagas disease as an etiological factor. Rev Esp Cardiol (2010) 0.87
Brain natriuretic peptide and left ventricular dysfunction in chagasic cardiomyopathy. Mem Inst Oswaldo Cruz (2004) 0.86
Infection-induced respiratory burst in BALB/c macrophages kills Leishmania guyanensis amastigotes through apoptosis: possible involvement in resistance to cutaneous leishmaniasis. Microbes Infect (2005) 0.85
The Valsalva maneuver in Chagas disease patients without cardiopathy. Int J Cardiol (2002) 0.85
Endogenous IL-4 and IFN-gamma are essential for expression of Th2, but not Th1 cytokine message during the early differentiation of human CD4+ T helper cells. Hum Immunol (2004) 0.84
A sensitive flow cytometric methodology for studying the binding of L. chagasi to canine peritoneal macrophages. BMC Infect Dis (2005) 0.83
Adhesion molecule expression patterns indicate activation and recruitment of CD4+ T cells from the lymph node to the peripheral blood of early cutaneous leishmaniasis patients. Immunol Lett (2003) 0.83
Schistosoma mansoni infection alters co-stimulatory molecule expression and cell activation in asthma. Microbes Infect (2008) 0.83
Interleukin-10 gene polymorphism (-1082G/A) is associated with toxoplasmic retinochoroiditis. Invest Ophthalmol Vis Sci (2008) 0.82
Implications of cytokine gene polymorphisms on the orchestration of the immune response: lessons learned from oral diseases. Cytokine Growth Factor Rev (2009) 0.81
Characterization of alpha-enolase as an interferon-alpha 2 alpha 1 regulated gene. Front Biosci (2005) 0.81
Interleukin-6 gene polymorphism (-174 G/C) is associated with toxoplasmic retinochoroiditis. Acta Ophthalmol (2013) 0.80
Functional capacity and right ventricular function in patients with Chagas heart disease. Eur J Echocardiogr (2010) 0.80
Left ventricular diastolic function and exercise capacity in patients with Chagas cardiomyopathy. Echocardiography (2010) 0.80
Warfarin drug interactions: a comparative evaluation of the lists provided by five information sources. Eur J Clin Pharmacol (2011) 0.80
Correlation between BNP levels and Doppler echocardiographic parameters of left ventricle filling pressure in patients with Chagasic cardiomyopathy. Echocardiography (2009) 0.80
Ischemic cerebrovascular events in patients with Chagas cardiomyopathy: a prospective follow-up study. J Neurol Sci (2009) 0.79
Trypanosoma cruzi: populations bearing opposite virulence induce differential expansion of circulating CD3+CD4-CD8- T cells and cytokine serum levels in young and adult rats. Exp Parasitol (2007) 0.78
Immunoregulatory and Effector Activities in Human Cutaneous and Mucosal Leishmaniasis: Understanding Mechanisms of Pathology. Drug Dev Res (2011) 0.78
Rifampicin-warfarin interaction leading to macroscopic hematuria: a case report and review of the literature. BMC Pharmacol Toxicol (2013) 0.78
Clinical aspects of Chagas disease and implications for novel therapies. Drug Dev Res (2011) 0.77
Low levels of vasoactive intestinal peptide are associated with Chagas disease cardiomyopathy. Hum Immunol (2013) 0.76
Brain natriuretic peptide measurement in Chagas heart disease: marker of ventricular dysfunction and arrhythmia. Int J Cardiol (2005) 0.76
Evaluation of alternative reporter genes for the yeast two-hybrid system. Genet Mol Res (2003) 0.76
A risk score for predicting death in Chagas' heart disease. N Engl J Med (2006) 0.76
Authors' reply (Should tissue Doppler echocardiography be used to improve prediction of mortality risk in patients with Chagas cardiomyopathy?). Int J Cardiol (2011) 0.75
Agreement among four drug information sources for the occurrence of warfarin drug interactions in Brazilian heart disease patients with a high prevalence of Trypanosoma cruzi infection. Eur J Clin Pharmacol (2012) 0.75
A comparison of ML Flow serology and slit skin smears to assess the bacterial load in newly diagnosed leprosy patients in Brazil. Lepr Rev (2008) 0.75
Transcription factor STAT1 gene polymorphism is associated with the development of severe forms of periodontal disease. Inflamm Res (2013) 0.75
Monocyte dysfunction in Sydenham's chorea patients. Hum Immunol (2010) 0.75